TY - CHAP
T1 - Real-time fluorescence image-guided oncologic surgery
AU - Mondal, Suman B.
AU - Gao, Shengkui
AU - Zhu, Nan
AU - Liang, Rongguang
AU - Gruev, Viktor
AU - Achilefu, Samuel
N1 - Funding Information:
Real-time image-guided surgery is gaining interest because of its potential to improve patient outcome following oncologic surgery. Not only can this approach guide intraoperative surgical margin assessment, the approach is uniquely positioned to detect microscopic tumors or residual lesions that are readily missed during surgery. Numerous types of optical imaging devices are available today to guide surgery. With the ever increasing miniaturization capability, simpler, smaller, and more efficient optical imaging systems will become available for clinical use in high- and low-resource clinical centers. Current bottleneck preventing full realization of the potential benefits of NIR fluorescence-guided surgery is the lack of FDA-approved tumor-selective molecular imaging agents. This missing link is expected to be rectified soon because of dedicated efforts by many investigators and some federal funding agencies such as the National Institutes of Health to support early phase clinical trials with novel imaging agents. Beyond identifying tumors, coupling therapeutic options to either the device or molecular probe arm of the technology could further enhance its potential clinical impact. 5-ALA is currently capable of achieving this goal by providing both imaging and therapeutic capabilities. Alternative theranostic platforms can be developed to harness the modular design of contrast agents and light-triggered drug release.
Publisher Copyright:
© 2014 Elsevier Inc.
PY - 2014
Y1 - 2014
N2 - Medical imaging plays a critical role in cancer diagnosis and planning. Many of these patients rely on surgical intervention for curative outcomes. This requires a careful identification of the primary and microscopic tumors, and the complete removal of cancer. Although there have been efforts to adapt traditional-imaging modalities for intraoperative image guidance, they suffer from several constraints such as large hardware footprint, high-operation cost, and disruption of the surgical workflow. Because of the ease of image acquisition, relatively low-cost devices and intuitive operation, optical imaging methods have received tremendous interests for use in real-time image-guided surgery. To improve imaging depth under low interference by tissue autofluorescence, many of these applications utilize light in the near-infrared (NIR) wavelengths, which is invisible to human eyes. With the availability of a wide selection of tumor-avid contrast agents, advancements in imaging sensors, electronic and optical designs, surgeons are able to combine different attributes of NIR optical imaging techniques to improve treatment outcomes. The emergence of diverse commercial and experimental image guidance systems, which are in various stages of clinical translation, attests to the potential high impact of intraoperative optical imaging methods to improve speed of oncologic surgery with high accuracy and minimal margin positivity.
AB - Medical imaging plays a critical role in cancer diagnosis and planning. Many of these patients rely on surgical intervention for curative outcomes. This requires a careful identification of the primary and microscopic tumors, and the complete removal of cancer. Although there have been efforts to adapt traditional-imaging modalities for intraoperative image guidance, they suffer from several constraints such as large hardware footprint, high-operation cost, and disruption of the surgical workflow. Because of the ease of image acquisition, relatively low-cost devices and intuitive operation, optical imaging methods have received tremendous interests for use in real-time image-guided surgery. To improve imaging depth under low interference by tissue autofluorescence, many of these applications utilize light in the near-infrared (NIR) wavelengths, which is invisible to human eyes. With the availability of a wide selection of tumor-avid contrast agents, advancements in imaging sensors, electronic and optical designs, surgeons are able to combine different attributes of NIR optical imaging techniques to improve treatment outcomes. The emergence of diverse commercial and experimental image guidance systems, which are in various stages of clinical translation, attests to the potential high impact of intraoperative optical imaging methods to improve speed of oncologic surgery with high accuracy and minimal margin positivity.
KW - Cancer
KW - Fluorescence
KW - Image-guided surgery
KW - Intraoperative imaging
KW - Optical
KW - Surgery
UR - http://www.scopus.com/inward/record.url?scp=84907819308&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84907819308&partnerID=8YFLogxK
U2 - 10.1016/B978-0-12-411638-2.00005-7
DO - 10.1016/B978-0-12-411638-2.00005-7
M3 - Chapter
C2 - 25287689
AN - SCOPUS:84907819308
T3 - Advances in Cancer Research
SP - 171
EP - 211
BT - Advances in Cancer Research
PB - Academic Press Inc.
ER -